Skip to main navigation Skip to search Skip to main content

The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study

  • Noor Mruwat
  • , Noga Givon-Lavi
  • , Ralf J. Ludwig
  • , Khalaf Kridin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)356-358
Number of pages3
JournalInternational Journal of Dermatology
Volume65
Issue number2
DOIs
StatePublished - Feb 2026
Externally publishedYes

Keywords

  • SGLT-2
  • autoimmune skin diseases
  • dipeptidyl-peptidase IV inhibitor
  • thiazolidinedione

Cite this